About 2,210 results

ALLMedicine™ Varicella-zoster Center

Research & Reviews  784 results

Zoster neuritis of lumbar nerves: A clinical, magnetic resonance imaging, and electrodi...
Journal of Postgraduate Medicine; Oak P, Modi T et. al.

Nov 23rd, 2021 - Human herpesviruses, particularly the varicella-zoster virus, are notorious for affecting the central nervous system, especially when secondarily reactivated from a latent state. We present one such case of zoster radiculitis with an ensemble of t...

The architecture of the simian varicella virus transcriptome.
PLoS Pathogens; Braspenning SE, Verjans GMGM et. al.

Nov 23rd, 2021 - Primary infection with varicella-zoster virus (VZV) causes varicella and the establishment of lifelong latency in sensory ganglion neurons. In one-third of infected individuals VZV reactivates from latency to cause herpes zoster, often complicated...

Herpes simplex viruses (1 and 2) and varicella-zoster virus infections in an adult popu...
Medicine Lee GH, Kim J et. al.

Nov 20th, 2021 - Three α-herpesviruses are known to be associated with central nervous system (CNS) infection; however, there are limited data on the incidence and clinical characteristics of α-herpesviruses CNS infections. This study aimed to assess the clinical ...

Zoster Cranial Polyneuropathy in a COVID-19 Patient.
The American Journal of Case Reports; Antonescu F, Butnariu I et. al.

Nov 18th, 2021 - BACKGROUND Ramsay Hunt syndrome is a rare form of herpes zoster caused by the reactivation of the varicella-zoster virus in the geniculate ganglion. The main clinical manifestations are peripheral facial palsy, vesicular rash in the ear, and ipsil...

Viral Infections and Pregnancy

Nov 11th, 2021 - Viral infections in pregnancy are major causes of maternal and fetal morbidity and mortality. Infections can develop in the neonate transplacentally, perinatally (from vaginal secretions or blood), or postnatally (from breast milk or other sources...

see more →

Guidelines  1 results

Updated recommendations for use of VariZIG--United States, 2013.
MMWR. Morbidity and Mortality Weekly Report;

Jul 19th, 2013 - In December 2012, the Food and Drug Administration (FDA) approved VariZIG, a varicella zoster immune globulin preparation (Cangene Corporation, Winnipeg, Canada) for use in the United States for postexposure prophylaxis of varicella for persons at...

see more →

Drugs  12 results see all →

Clinicaltrials.gov  8 results

Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox

Nov 1st, 2021 - Varicella (chickenpox) results from primary infection with VZV. Varicella, a common and usually benign illness in normal children, is more severe in HIV-infected children and may result in other conditions such as HZ (shingles). HZ is due to react...

A Study of an Investigational V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine in Immunocompromised Adults (V212-002)

May 20th, 2019 - This study will evaluate the safety and immunogenicity of a heat-treated VZV vaccine in autologous or allogeneic hematopoietic cell transplant (HCT) recipients, human immunodeficiency virus (HIV)-infected participants with a baseline cluster of di...

Herpes Zoster Vaccine for Bone Marrow Transplant Donors

May 11th, 2018 - Infection is a major cause of morbidity and death among haemopoietic stem cell transplantation patients (HSCTs). Beyond the initial post-transplant (BMT) phase of neutropenia, the most common infections are cytomegalovirus (CMV) and fungal infecti...

An Effectiveness and Safety Study With RWJ-333369 (Carisbamate) for the Study of Postherpetic Neuralgia (PHN).

May 1st, 2018 - Postherpetic neuralgia is a distressing syndrome of neuropathic pain that continues for at least 3 months after the resolution of the varicella-zoster rash (shingles), can last up to years later, and for which therapies are often limited by incomp...

Civamide Nasal Solution for Postherpetic Neuralgia of the Trigeminal Nerve

Mar 1st, 2017 - Herpes zoster (commonly referred to as "shingles") results from the reactivation of the varicella-zoster virus acquired during a primary infection, usually chickenpox. The virus lays dormant in the cells of the nerves until activated. Once activat...

see more →

News  74 results

Atopic Dermatitis and the Risk of Infections

Nov 14th, 2021 - Takeaway Atopic dermatitis (AD) was associated with an increased risk of hospitalised infections, opportunistic infections and several herpesvirus infections in both children and adults, with the risk being greatest in those with severe skin disea...

The Link Between Shingles, Zostavax Vaccination and Dementia Risk

Oct 15th, 2021 - Takeaway Participants who were diagnosed with shingles at ≥3 years prior to dementia diagnosis had a slight but non-significant increase in the risk of dementia. The risk of dementia was lower in participants who were vaccinated with Zostavax. Why...

Acyclovir-Resistant Cutaneous Herpes Simplex Virus in DOCK8 Deficiency
Christina R. Hopkins, MD, Nicholas Lowe, MD et. al.

Oct 12th, 2021 - Dedicator of cytokinesis 8 (DOCK8 ) deficiency is the major cause of autosomal-recessive hyper-IgEsyndrome. 1 Characteristic clinical features including eosinophilia, eczema, and recurrent Staphylococcus aureus cutaneous and respiratory tract infe.

Live Varicella Zoster Vaccine Safe, Effective With TNF Inhibitors

Sep 30th, 2021 - (Reuters Health) - Adults 50 years and older who take tumor necrosis factor inhibitors (TNFis) for a range of inflammatory disorders can receive effective protection from shingles with a live varicella zoster vaccine, a clinical trial suggests. Re...

Fatal Measles Case Caused by Vaccine in Immunocompromised Teen

Sep 23rd, 2021 - (Reuters Health) - A team of doctors in Los Angeles and Atlanta is calling for renewed vigilance to screen children for immune system problems before vaccination after an undocumented 17-year-old girl received the measles vaccine and died from the...

see more →

Patient Education  5 results see all →